Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Deals & Financings

VC fundings, mergers and acquisitions, and other financing events...

Zai Lab Raises $261 Million; Plans China NDA Filing for Ripretinib in Mid-2020

Beijing Hengsheng Medical Completes $6 Million Funding for Coronary Devices

China Medical In-licenses China Rights to Novel Anemia Drug from Zydus Cadila

Oncologie Collaborates with Genialis to Identify Patients for Clinical Trials

Celltrion Plans $513 Million Wuhan Biologics Facility; 18 Biologic Launches in China by 2030

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China